Valbona Aliko, Full Professor in Animal EcoToxicoPhysiology, Department of Biology, Faculty of Natural Sciences, University of Tirana, Albania. Leader of NanoToxicology NanoAlb Research Group and Coordinator of NanoAlb PhD Programme-Quartz, Albanian Academy of Science. Research interests focused on studying the mechanisms of adaptive response of animals to environmental stress (heavy metals, pesticides, nanoparticles), by using multi-biomarker approach and designing & bio-functionalizing biosensors with possible application in monitoring environmental pollution and biota health

Dr. Ruslan Álvarez Diduk obtained his PhD in chemistry at the Universidad Autónoma Metropolitana (México) in 2014. From 2015 to date, he works as a postdoctoral researcher in the Nanobioelectronics and Biosensors group (Prof. Merkoçi). His research focuses on the development of novel nanostructured biosensors using both optical and electrochemical platforms, which are based on point-of-care and low-cost systems. He is also involved in exploring new and novel routes for nanoparticle synthesis, graphene reduction and laser patterning, and the development of readout platforms including smartphone based biosensing

Giuseppe De Rosa is full professor at the Department of Pharmacy, University of Naples Federico II. His scientific activity is focused on drug delivery systems, especially liposomes, self-assembling nanoparticles and lipid nanoparticles. The scientific production is described in about 110 papers (H-index: 37) on international journals, 5 book chapters and different patent applications (with granted PCT, US and EU patent). One of the products patented and in development received the orphan designation by European Medicine Agency and by the Food and Drug Administration in 2016. For his research activity, G. De Rosa received different financial support, among them one by MIUR (Italian Minister for the University and Research), Ministero della Salute (Italian Minister of Health) and the Phospholipid Research Center of Heidelberg (Germany). G. De Rosa is member of the Editorial Board of different journals in the field of drug delivery and pharmaceutics. He also collaborates as referee with several international journals.

from 2010 to now Full Professor – President of the Faculty of Pharmacy
from 2011 to now Full Professor – Coordinator of the pharmaceutical science curriculum of the PhD Course in Life Sciences
rom 2010 to now Vice-President of the Board of the Professional Association of Pharmacists
from 2002 to 2011 Full Professor – Coordinator of the PhD Course in Pharmaceutical Sciences
from 2002 to 2010 Full Professor
from 2000 to 2002 Associate Professor
from 1996 to 2000 Assistant Professor
from 1992 to 1994 Visiting Scientist

Lopedota Angela Assunta is an Associate Professor of Pharmaceutical Technology and Regulatory Affairs at the University of Bari Aldo Moro, Italy. In 2023, she achieved national habilitation as a Full Professor. Her research portfolio includes 111 peer-reviewed publications (h-index: 32; 2,684 citations), as well as national and international patents and numerous conference presentations. Her work primarily focuses on developing innovative formulations for age-related conditions, particularly addressing the needs of paediatric patients. Additionally, she specializes in enhancing the biopharmaceutical properties of drugs and the application of mucoadhesive polymers in drug delivery. Angela is also skilled in advanced techniques such as prilling, vibration spray drying, microfluidics, and 3D printing. She possesses extensive teaching experience in Pharmaceutical Technology at both undergraduate and postgraduate levels, in Italy and Albania.

Dr. Sergio E. Moya is at group leader at CIC biomaGUNE, San Sebastian, Spain. Sergio got a degree in Chemistry at the National University of the South Argentina, and a PhD in Physical Chemistry at the University of Potsdam, Germany, working at the Max Planck Institute of Colloids and Interfaces. He did post docts at the College de France in Paris, and at the University of Cambridge, UK. His group at CIC biomaGUNE works on soft materials for biomedical applications with a focus on physico chemical aspects, bio nano interactions and biological fate.He has published more than 270 articles in different areas of Chemistry, Soft Matter and Nanomedicine

Prof. Rosario Pignatello is Full Professor of Pharmaceutical Technology and Legislation at the University of Catania. He is the actual Director of the Department of Drug and Health Sciences (DSFS). His main teaching tasks concern Pharmaceutical Technology & Pharmaceutics, Drug Delivery and Targeting, Pharmaceutical and Health Legislation, Environmental Legislation. He is a member of the Teachers Council of the Research Doctorate (PhD) in ‘Neuroscience’ (University of Catania). He acted as an independent expert for the European Commission in the evaluation of research project applications within the 6th and 7th Framework, and Horizon2020 Programmes. He is member of Controlled Release Society (CRS - Italy Chapter) and of ADRITELF (Italian Association of Teachers and Researchers of Pharmaceutical Technology and Legislation). He acts as a Scientific consultant of several Companies operating in the fields of medicine and health product (medical devices, food supplements).

Carlos J Rodríguez-Hernández received a PhD in Biotechnology in 2006 from the Universitat Politècnica de València (Spain). During his PhD training he focused in the molecular mechanism of the diabetogenic properties of the immunosuppressant Tacrolimus. In 2007 he joined the JJ Guinovart's Metabolic Engineering and Diabetes Therapy Laboratory at the IRB-Barcelona to study the antitumoral use of an antidiabetic compound and assess the hepatotoxicity of drugs in development by Noscira (Zeltia).

Prof. Asoc. Dr. Kleva Shpati completed her studies at the University of Tirana, Faculty of Medicine, Department of Pharmacy. In 2003, at the Faculty of Medicine, she completed her postgraduate studies in Pharmaceutical Sciences and in 2013 earned the "Doctor" degree at the same University with the thesis "Biopharmaceutical Aspects of the Use of Statins in our Country". In 2007, Dr. Kleva Shpati completed the "Insitute Francais de Gestion" Master Degree at the University of Bordeaux in collaboration with the Polytechnic University of Tirana. Since 2007, Dr. Kleva Shpati is a full-time professor at the Department of Pharmacy, Albanian University, and since March 2018 up to date holds the position of Head of Pharmacy Department. Dr. Kleva Shpati is the author of several publications of scientific articles and participant in national and international conferences, as well as co-author of the book for the students of medical sciences and pharmaceuticals "Bio-pharmacy and Pharma-concientics".

Prof. Francesco Trotta has more than thirty years of teaching activity at the University of Turin, at the Turin Polytechnic, the University of Calabria and, as visiting professor, at the Jan Dlugosz University in Czestochowa. He is author and co-author of 272 scientific publications, 20 industrial patents, 2 books, 7 book chapters, 2 items of the Encyclopedia of Membrane and more than 250 communications to national and international conferences. He has 10,113 citations and h-index 58. He is in the top 3% in World Scientist Ranking by the Stanford University AD Scientific Index 2024. He is considered the godfather of the cyclodextrin-based polymer nanosponges, a material world-wide recognized by the carbohydrate community.

Dr. Merita Xhetani is Associate Professor, member of Department of Biology, and Head of the Center of Molecular Diagnostics and Genetic Research, University Hospital Obstetrics and Gynecology “Queen Geraldine”, in Tirana, Albania. Her lab’s research is primarily the study of hematopoietic disorders, with a focus on the regulation of erythropoiesis, on disease model development and in particular on gene therapy of β-thalassemia. Recently Merita’s work is focused on applying genome editing tools for genetic engineering of blood cells and contributions to the field involve applying precise gene editing to monogenic blood disorders. She attended many training courses in molecular genetics in different European countries and recently completed her postdoctoral studies in Functional Genomics at LFKRI, Research Institute, New York Blood Center, NY, USA, supported by the Fulbright research program. She is also chair of the Albanian Society of Human Molecular Genetics